Periodic Reporting for period 4 - TKI resistance (Resistance mechanisms to tyrosine kinase inhibitors in solid tumors)

‘Precision medicine’ is based on the selection of therapeutic agents for each individual patient based on the mutations, translocations and copy number variations identified in their cancer cells. In tumors in which such genetic alterations could be identified (i.e. 20-40%...